Stay updated on Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.

Latest updates to the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page
- Check2 days agoChange DetectedVersion metadata updated from v3.3.3 to v3.3.4; no changes to study content or visible page details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a consolidated Locations section listing all participating states. Removed separate per-state location sections and the HHS Vulnerability Disclosure link.SummaryDifference1%

- Check51 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no user-visible changes to the study details or page layout were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedDeletion of the government funding notice about potential delays in website updates and responses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThe screenshots show the same study page with no substantive changes to core content.SummaryDifference0.4%

- Check102 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%

Stay in the know with updates to Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.